Armistice Capital’s Vanda Pharmaceuticals VNDA Stock Holding History

Armistice Capital’s Portfolio VNDA Stock Details VNDA Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,965,000	Closed	-$33.7M	–	177
2021 Q3	$33.7M	Sell	1,965,000 -749,000	-28%	-$12.8M	0.57%	50
2021 Q2	$58.4M	Sell	2,714,000 -1,082,000	-29%	-$23.3M	1.05%	20
2021 Q1	$57M	Sell	3,796,000 -1,603,277	-30%	-$24.1M	1.31%	20
2020 Q4	$70.9M	Sell	5,399,277 -50,723	-0.9%	-$666K	2.41%	3
2020 Q3	$52.6M	Buy	5,450,000 +650,000	+14%	+$6.28M	1.91%	10
2020 Q2	$54.9M	Buy	4,800,000 +232,000	+5%	+$2.65M	2.41%	6
2020 Q1	$47.3M	Buy	4,568,000 +1,740,000	+62%	+$18M	2.93%	3
2019 Q4	$46.4M	Sell	2,828,000 -720,000	-20%	-$11.8M	2.68%	3
2019 Q3	$47.1M	Buy	3,548,000 +390,000	+12%	+$5.18M	3.12%	3
2019 Q2	$44.5M	Buy	+3,158,000	New	+$44.5M	2.81%	4
2018 Q4	–	Sell	-900,000	Closed	-$20.7M	–	93
2018 Q3	$20.7M	Sell	900,000 -1,324,000	-60%	-$30.4M	1.24%	23
2018 Q2	$42.4M	Sell	2,224,000 -376,000	-14%	-$7.16M	2.77%	5
2018 Q1	$43.8M	Sell	2,600,000 -78,000	-3%	-$1.31M	3.35%	2
2017 Q4	$40.7M	Buy	2,678,000 +1,146,000	+75%	+$17.4M	4.06%	2
2017 Q3	$27.4M	Sell	1,532,000 -532,000	-26%	-$9.52M	3.23%	1
2017 Q2	$33.6M	Buy	2,064,000 +456,000	+28%	+$7.43M	4.29%	1
2017 Q1	$22.5M	Buy	1,608,000 +1,028,000	+177%	+$14.4M	4.65%	2
2016 Q4	$9.25M	Buy	580,000 +30,000	+5%	+$479K	2.19%	16
2016 Q3	$9.15M	Sell	550,000 -250,000	-31%	-$4.16M	2.94%	7
2016 Q2	$8.95M	Sell	800,000 -800,000	-50%	-$8.95M	3.41%	2
2016 Q1	$13.4M	Sell	1,600,000 -30,000	-2%	-$251K	5.25%	2
2015 Q4	$15.2M	Buy	1,630,000 +870,000	+114%	+$8.1M	5.41%	2
2015 Q3	$8.57M	Sell	760,000 -382,000	-33%	-$4.31M	2.93%	12
2015 Q2	$14.5M	Sell	1,142,000 -1,142,000	-50%	-$14.5M	5.21%	4
2015 Q1	$21.2M	Buy	2,284,000 +1,556,000	+214%	+$14.5M	9.41%	1
2014 Q4	$10.4M	Buy	+728,000	New	+$10.4M	5.01%	3